- Home
- EYPT vs TLRY Comparison
EYPT vs TLRY Comparison
Compare EYPT & TLRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EYPT
- TLRY
- Stock Information
- Founded
- EYPT 1987
- TLRY N/A
- Country
- EYPT United States
- TLRY Canada
- Employees
- EYPT N/A
- TLRY N/A
- Industry
- EYPT Biotechnology: Laboratory Analytical Instruments
- TLRY Medicinal Chemicals and Botanical Products
- Sector
- EYPT Industrials
- TLRY Health Care
- Exchange
- EYPT Nasdaq
- TLRY Nasdaq
- Market Cap
- EYPT 741.0M
- TLRY 624.7M
- IPO Year
- EYPT 2005
- TLRY 2018
- Fundamental
- Price
- EYPT $11.09
- TLRY $1.03
- Analyst Decision
- EYPT Strong Buy
- TLRY Hold
- Analyst Count
- EYPT 7
- TLRY 3
- Target Price
- EYPT $24.29
- TLRY $1.38
- AVG Volume (30 Days)
- EYPT 643.4K
- TLRY 78.6M
- Earning Date
- EYPT 08-06-2025
- TLRY 10-09-2025
- Dividend Yield
- EYPT N/A
- TLRY N/A
- EPS Growth
- EYPT N/A
- TLRY N/A
- EPS
- EYPT N/A
- TLRY N/A
- Revenue
- EYPT $51,898,000.00
- TLRY $821,309,000.00
- Revenue This Year
- EYPT N/A
- TLRY $8.95
- Revenue Next Year
- EYPT N/A
- TLRY $4.76
- P/E Ratio
- EYPT N/A
- TLRY N/A
- Revenue Growth
- EYPT 2.99
- TLRY 4.10
- 52 Week Low
- EYPT $3.91
- TLRY $0.35
- 52 Week High
- EYPT $13.99
- TLRY $1.98
- Technical
- Relative Strength Index (RSI)
- EYPT 61.85
- TLRY 64.74
- Support Level
- EYPT $10.22
- TLRY $0.55
- Resistance Level
- EYPT $11.28
- TLRY $1.37
- Average True Range (ATR)
- EYPT 0.71
- TLRY 0.12
- MACD
- EYPT 0.04
- TLRY 0.05
- Stochastic Oscillator
- EYPT 89.89
- TLRY 58.54
About EYPT EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.
About TLRY Tilray Brands Inc.
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. USA exposure consists of CBD products and alcohol.